Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)

Andreas Mugge

St. Josef Hospital, 
Bochum, NW, DE 
Advanced in Heart Failure with Preserved Ejection Fraction (HFpEF)
St. Josef Hospital, 
Bochum, NW, DE 
OverviewLocationsClinical Research

Overview

Andreas Mugge practices in Bochum, Germany. Mr. Mugge is rated as an Advanced expert by MediFind in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF). His top areas of expertise are Brugada Syndrome, Cardiac Arrest, Ventricular Fibrillation, Cardiac Ablation, and Transcatheter Aortic Valve Replacement (TAVR).

His clinical research consists of co-authoring 201 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Heart Failure with Preserved Ejection Fraction (HFpEF).

Gender
Male

Locations

St. Josef Hospital, Bochum, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Randomized, Multi-Center, Event-Driven Trial of TAVI Versus SAVR in Patients With Symptomatic Severe Aortic Valve Stenosis and Intermediate Risk of Mortality, as Assessed by STS-Score - DEDICATE
Enrollment Status: Active_not_recruiting
Publish Date: April 26, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
German-Austrian Register to Evaluate the Short and Long-term Safety and Therapy Outcomes of the ABSORB Everolimus-eluting Bioresorbable Vascular Scaffold System in Patients With Coronary Artery Stenosis
Enrollment Status: Completed
Publish Date: April 01, 2022
Intervention Type: Device
View 1 Less Clinical Trial

201 Total Publications

Publisher Correction: Circumstances in a young German cohort with sudden cardiac arrest: systematic insights and implications.
Publisher Correction: Circumstances in a young German cohort with sudden cardiac arrest: systematic insights and implications.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: March 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mugge's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 31 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile